Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Deferred Income Taxes
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Deferred Income Taxes of $1.60 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2019-03-13
- Crinetics Pharmaceuticals, Inc. increase (decrease) in deferred income taxes for fiscal 2018 was $1.60M.
| Period end | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|
| 2018-12-31 | $1.60M 10-K · filed 2019-03-13 |